Financials Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2024-05-23 pm EDT 5-day change 1st Jan Change
43.17 USD -0.76% Intraday chart for Qiagen N.V. -6.13% -3.58%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,655 12,018 12,618 11,355 9,910 9,650 - -
Enterprise Value (EV) 1 8,608 13,226 13,495 12,529 10,362 9,901 9,393 9,052
P/E ratio -188 x 34.5 x 25.1 x 27.1 x 30.3 x 23.7 x 21.3 x 19.1 x
Yield - - - - - - - -
Capitalization / Revenue 5.02 x 6.43 x 5.6 x 5.3 x 5.04 x 4.81 x 4.52 x 4.22 x
EV / Revenue 5.64 x 7.07 x 5.99 x 5.85 x 5.27 x 4.93 x 4.4 x 3.96 x
EV / EBITDA 15.6 x 17.7 x 15.3 x 15.9 x 15.7 x 13.8 x 12 x 10.6 x
EV / FCF 40.4 x 40.7 x 30 x 21.4 x 33.5 x 19.8 x 19.2 x 18.7 x
FCF Yield 2.47% 2.46% 3.33% 4.68% 2.99% 5.06% 5.22% 5.35%
Price to Book 3.08 x 4.31 x 4.08 x 3.28 x 2.71 x 2.43 x 2.2 x 2.01 x
Nbr of stocks (in thousands) 219,691 220,581 220,214 220,869 221,337 221,847 - -
Reference price 2 34.85 54.48 57.30 51.41 44.77 43.17 43.17 43.17
Announcement Date 2/4/20 2/9/21 2/8/22 2/10/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,526 1,870 2,252 2,142 1,965 2,007 2,137 2,285
EBITDA 1 551.8 747.8 884.2 789.7 659 716.3 780.6 851.4
EBIT 1 421.8 626.8 755 656.3 528.6 562.3 613.2 669.8
Operating Margin 27.63% 33.51% 33.53% 30.65% 26.9% 28.02% 28.7% 29.32%
Earnings before Tax (EBT) 1 -77.78 439.5 625.8 512.6 429.8 509 566.6 630.7
Net income 1 -41.46 359.2 512.6 423.2 341.3 406.7 450 508.7
Net margin -2.72% 19.2% 22.77% 19.76% 17.37% 20.27% 21.06% 22.27%
EPS 2 -0.1856 1.577 2.278 1.897 1.480 1.823 2.025 2.260
Free Cash Flow 1 212.9 325 449.1 586 309.7 500.8 490.4 484.3
FCF margin 13.95% 17.38% 19.95% 27.37% 15.76% 24.96% 22.95% 21.2%
FCF Conversion (EBITDA) 38.58% 43.46% 50.79% 74.21% 47% 69.92% 62.82% 56.88%
FCF Conversion (Net income) - 90.49% 87.61% 138.47% 90.75% 123.14% 108.97% 95.2%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/4/20 2/9/21 2/8/22 2/10/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 582 628.4 516 500 498 485.4 494.9 475.9 509.2 458.8 496.2 506.5 537.9 489.3 525.4
EBITDA 1 231.6 266.4 178.7 175.9 168.6 157.6 168 158.2 175.3 153.3 171.2 180.1 196.7 165.7 180.4
EBIT 1 199.3 231.6 146.2 143.5 134.9 124.2 135.6 126.4 142.4 117.8 135.4 143.6 160.4 129.9 147
Operating Margin 34.24% 36.86% 28.33% 28.7% 27.09% 25.59% 27.4% 26.56% 27.97% 25.68% 27.29% 28.35% 29.82% 26.54% 27.98%
Earnings before Tax (EBT) - - - 95.72 - - - - - - - - - - -
Net income 1 129.2 155.3 96.66 82.39 88.84 85.04 80.79 77.82 97.66 80.67 102.9 108.4 120.4 97.57 113.8
Net margin 22.2% 24.72% 18.73% 16.48% 17.84% 17.52% 16.33% 16.35% 19.18% 17.58% 20.73% 21.4% 22.39% 19.94% 21.66%
EPS 2 0.5773 0.6907 0.4330 0.3711 0.4021 0.3814 0.3608 0.3505 0.4200 0.3600 0.4550 0.4784 0.5316 0.4394 0.5123
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/8/22 4/27/22 7/26/22 11/7/22 2/10/23 5/3/23 8/8/23 10/30/23 2/6/24 4/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 953 1,208 876 1,174 452 251 - -
Net Cash position 1 - - - - - - 257 598
Leverage (Debt/EBITDA) 1.727 x 1.615 x 0.9912 x 1.486 x 0.6859 x 0.3497 x - -
Free Cash Flow 1 213 325 449 586 310 501 490 484
ROE (net income / shareholders' equity) 12.9% 18.9% 17.4% 12.9% 4.69% 11.9% 12% 12%
ROA (Net income/ Total Assets) 6.06% 9.02% 8.53% 6.81% 2.75% 7.39% 7.74% 8.04%
Assets 1 -684.1 3,982 6,008 6,217 12,403 5,504 5,816 6,331
Book Value Per Share 2 11.30 12.70 14.10 15.70 16.50 17.70 19.60 21.50
Cash Flow per Share 2 1.470 2.020 2.840 3.200 1.990 2.670 2.840 2.920
Capex 1 118 133 190 129 150 158 170 182
Capex / Sales 7.73% 7.1% 8.43% 6.03% 7.62% 7.88% 7.97% 7.96%
Announcement Date 2/4/20 2/9/21 2/8/22 2/10/23 2/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.17 USD
Average target price
50.14 USD
Spread / Average Target
+16.14%
Consensus
  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. Financials Qiagen N.V.